JH
Jeffrey Hung Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
53
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
57.1%
Neutral
42.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $226 |
22%
upside
| 1 | +4% |
0
%
| 25 Feb ‘26 8 days ago |
|
|
|
Overweight
Maintained
| $92 |
48%
upside
| 1 | +6.3% |
0
%
| 23 Feb ‘26 10 days ago |
|
|
|
Equal-Weight
Downgraded
| $14 |
3%
upside
| 1 | +31% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Equal-Weight
Downgraded
| $175 |
35%
upside
| 1 | +4% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $80 |
107%
upside
| 1 | -7.4% |
0
%
| 6 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $71 |
15%
upside
| 1 | -6% |
0
%
| 23 Dec ‘25 2 months ago |
|
|
|
Equal-Weight
Upgraded
| $12 |
43%
downside
| 1 | -159% |
0
%
| 8 Dec ‘25 2 months ago |
|